Evidence map›Paper›PMID 17823278›Full record

ArticleThe American journal of pathology2007

Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors.

Yuko Iwata, Yuki Katanosaka, Takashi Hisamitsu, Shigeo Wakabayashi

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. CaBiomolecules · 2025
    Review
  2. Review
  3. P2 Receptor Signaling in Motor Units in Muscular Dystrophy.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Dysferlin and animal models for dysferlinopathy.Journal of toxicologic pathology · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yuko IwataDepartment of Molecular Physiology, National Cardiovascular Center Research Institute, Suita, Osaka, Japan. wak@ri.ncvc.go.jp
Yuki Katanosaka
Takashi Hisamitsu
Shigeo Wakabayashi
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A subset of muscular dystrophy is caused by genetic defects in dystrophin-associated glycoprotein complex. Using two animal models (BIO14.6 hamsters and mdx mice), we found that Na(+)/H(+) exchanger (NHE) inhibitors prevented muscle degeneration. NHE activity was constitutively enhanced in BIO myotubes, as evidenced by the elevated intracellular pH and enhanced (22)Na(+) influx, with activation of putative upstream kinases ERK42/44. NHE inhibitor significantly reduced the increases in baseline intracellular Ca(2+) as well as Na(+) concentration and stretch-induced damage, suggesting that Na(+)(i)-dependent Ca(2+)overload via the Na(+)/Ca(2+) exchanger may cause muscle damage. Furthermore, ATP was found to be released continuously from BIO myotubes in a manner further stimulated by stretching and that the P2 receptor antagonists reduce the enhanced NHE activity and dystrophic muscle damage. These observations suggest that autocrine ATP release may be primarily involved in genesis of abnormal ionic homeostasis in dystrophic muscles and that Na(+)-dependent ion exchangers play a critical pathological role in muscular dystrophy.

Indexed as

Adenosine TriphosphateAmilorideAnimalsCalciumCations, DivalentCells, CulturedCricetinaeGuanidinesIon TransportMiceMice, Inbred mdxMuscle Fibers, SkeletalMuscular Dystrophy, AnimalPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2SodiumAdenosine TriphosphateAmilorideCalciumcariporideCations, DivalentethylisopropylamilorideGuanidinesPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2SodiumSodium-Calcium ExchangerSodium-Hydrogen ExchangersSulfones

Identifiers

PMID17823278
PMCPMC2043518
OpenAlexW2017306120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.